Hoge kwaliteit - Belgian Biosafety Server

More documents

Recommendations

Info

Het Wetenschappelijk Instituut Volksgezondheid, Belgisch brandpunt voor Bioveiligheid 1990-2010: 20 jaar risicobeoordeling van GGO’s en pathogenen D. Breyer, P. Daubresse, M. Sneyers (2007). Bringing scientists to the people - the Co-Extra website. Biotechnology Journal, 2 (9), 1081 -1085. A. De Schrijver, Y. Devos, M. Van den Bulcke, P. Cadot, M. De Loose, D. Reheul, M. Sneyers (2007). Risk assessment of GM stacked events obtained from crosses between GM events. Trends in Food Science and Technology, 18, 101-109. K. Pauwels, P. Herman, B. Van Vaerenbergh, CD. Do thi, L. Berghmans, G. Waeterloos, D. Van Bockstaele, K. Dorsch-Häsler, M. Sneyers (2007). Animal Cell Cultures: Risk Assessment and Biosafety Recommendations. Applied Biosafety, 12 (1), 27-39. Y Devos, D Reheul, A De Schrijver (2006). Considerations of cross-fertilization between GM and non-GM maize. ISB News Report, March 2006. M. Sneyers, P. Herman, W. Moens (2005). Polio eradication and laboratory containment program of wild polioviruses in Belgium. Laboratory survey and inventory phase. Archives of Public Health. 63, 57-65. Y. Devos, D. Reheul, A. De Schrijver (2005). The co-existence between transgenic and non-transgenic maize in the European Union: a focus on pollen flow and cross-fertilization. Environmental Biosafety Research, 4, 71-87. P. Herman, Y. Verlinden, D. Breyer, E. Van Cleemput, B. Brochier, M. Sneyers, R. Snacken, P. Hermans, P. Kerkhofs, C. Liesnard, B. Rombaut, M. Van Ranst, G. Van Der Groen, P. Goubau, W. Moens (2004). Biosafety risk assessment of the severe acute respiratory syndrome (SARS) Coronavirus and containment measures for the diagnostic and research laboratories. Applied Biosafety. 9 (3), 128-142. Y. Devos, D. Reheul, A. De Schrijver, F. Cors, W. Moens (2004). Management of herbicide-tolerant oilseed rape in Europe: a case study on minimizing vertical gene flow. Environmental Biosafety Research, 3, 135-148. Biosafety of Virus-Derived Vectors. Moens W. (Guest Editor). Current Gene Therapy, 2003, 3 (6), 493 (Le SBB a été l’éditeur de cette revue internationale consacrée à la biosécurité des vecteurs viraux avec les chercheurs et cliniciens des universités de Leuven, Bruxelles, Liège, de l’Institut Rega, du CODA-CERVA et de la spin-off Henogen de Gosselies). Y. Devos and A. De Schrijver (2003). Genetisch gewijzigd voedsel: Reglementering en veiligheidsbeoordeling. Nutrinews, 3, 12-17. M. Sneyers, J-C. Dumon, B. Van Vaerenbergh, W. Moens (2001). Gene Therapy Clinical Trials in Belgium. Human Gene Therapy, 12, 1361-1365. D. Breyer and W. Moens (2000). Le protocole sur la biosécurité: test de crédibilité pour l’avenir de la Convention sur la diversité biologique ? Bulletin de l'Institut Royal des Sciences naturelles de Belgique, 70-Suppl, 45-52. 160
Het Wetenschappelijk Instituut Volksgezondheid, Belgisch brandpunt voor Bioveiligheid 1990-2010: 20 jaar risicobeoordeling van GGO’s en pathogenen O. Doblhoff-Dier H. Bachmayer, A. Bennett, G. Brunius, M. Cantley, C. Collins, J-M. Collard, P. Crooy, A. Elmqvist, C. Frontali-Botti, H.G. Gassen, R. Havenaar, H. Haymerle, D. Lamy, M. Lex, J.L. Mahler, L. Martinez, C. Mosgaard, L. Olsen, J. Pazlarova, F. Rudan, M. Sarvas, H. Stepankova, G. Tzotzos, K. Wagner and R. Werner (2000). Safe Biotechnology. 10. DNA content of biotechnological process waste. Trends in Biotechnol. (TIBECH). 18, 141-46. O. Doblhoff-Dier, H. Bachmayer, A. Bennett, G. Brunius, K. Bürki, M. Cantley, JM. Collard, C. Collins, P. Crooy, A. Elmqvist, C. Frontali-Botti, R. Havenaar, H. Haymerle, H. Lelieveld, M. Lex, J. L. Mahler, L. Martinez, C. Mosgaard, L. Olsen, J. Pazlarova, F. Rudan, M. Sarvas, H. Stepankova, G. Tzotzos, K. Wagner and R. Werner (1999). Safe Biotechnology. 9: value in risk assessment for the environmental application of microorganisms. Trends in Biotechnol. (TIBECH), 17, 307-311. M. Sneyers (1999). Regulation of Gene Therapy in Belgium. Euregenethy, a scientific network of users. Regulation of Gene Therapy in Europe, 1, 3-5. J.M. Collard, D. Breyer, M. Sneyers, B. Van Vaerenbergh, W. Moens (1998). Manipulation d'organismes pathogènes ou génétiquement modifiés dans les hôpitaux. Aspects biosécuritaires et réglementaires. L'Hôpital Belge/Het Belgisch Ziekenhuis. 4, 55-62. H. L. M. Lelieveld, H. Bachmayer, B. Boon, A. Bennett, G. Brunius, K. Bürki, M. Cantley, J.M. Collard, C.H. Collins, P.Crooy, O. Doblhoff-Dier, R. Dubakiene, I. Economidis, A. Elmqvist, C. Frontali-Botti, R. Havenaar, H. Haymerle, O. Käppeli, G. Leaver, M. Lex, S. Lund, J. L. Mahler, R. Marris, L. J. Martinez, C. Mosgaard, M. Nicu, C. Normand-Plessier, J. Olsen, J. Pazlerova, M. Romantschuk, F. Rudan, M. Sarvas, H.- D. Schlumberger, G. Szvoboda, H. Stepankova, G. Tzotzos, V. Vaicuivenas, K. Wagner, R. G. Werner, A. Zhilevicha (1997). Safe Biotechnology. 8. Transport of infectious and biological materials. Appl. Microbiol. Biotechnol. 48, 135-140. WETENSCHAPPELIJKE RAPPORTEN EN AANBEVELINGEN INZAKE BIOVEILIGHEID 142 A. Leunda, K. Pauwels, B. Van Vaerenbergh, P. Herman (2010). Sampling feasibility study of pathogenic organisms genetically modified or not in contained use activities. Ref : D/2010/2505/19. K. Pauwels, C. Verheust, B. Van Vaerenbergh, P. Herman (2009). Biological Risk Assessment Sheets: Practical Examples of Risk Assessment and Biosafety Recommendations for the Contained Use of Genetically Modified (Micro-)Organisms. Ref : D/2009/2505/48. A. Leunda Casi, K. Pauwels, P. Herman, C. Verheust, W. Zorzi, O. Thellin, B. Van Vaerenbergh (2009). Risk assessment of laboratories involving the manipulation of unconventional agents causing TSE. Ref : D/2009/2505/49. 142 De volledige lijst van de rapporten van de SBB staat op de website van het WIV-ISP (http://www.wiv-isp.be) 161
Page 4 and 5:
Het Wetenschappelijk Instituut Volk
Page 6 and 7:
Page 8 and 9:
Page 10 and 11:
Page 12 and 13:
Page 14 and 15:
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
ACTIVITEITEN VAN DE OESO Het Wetens
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Medicinale producten Het Wetenschap
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111: Het Wetenschappelijk Instituut Volk
Page 114 and 115: aantal dossiers behandeld 7 6 5 4 3
Page 116 and 117: Het geval Gelsinger Het Wetenschapp
show all

Hoge kwaliteit - Belgian Biosafety Server

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?